ASPIRIN
- Product NDC
- 68210-4093
- Requested package NDC
- 68210-4093-1
- 11-digit product format
- 682104093
- Labeler code
- 68210
- Product ID
- 68210-4093_eec8fcc5-8b9a-c73e-e053-2a95a90a3772
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ASPIRIN
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- SPIRIT PHARMACEUTICALS LLC
- Application
- part343
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2020-07-02
- Marketing end
- 0000-00-00
- Substance
- ASPIRIN
- Active strength
- 325 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68210-4093-1 | ASPIRIN | 300 in 1 BOTTLE | TABLET, DELAYED RELEASE | 300 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68210-4093 | ASPIRIN TABLET, DELAYED RELEASE [SPIRIT PHARMACEUTICALS LLC] | 6 | Legacy NDC, 1 package rows | 20241211_a9cf438d-b424-4b40-9cc2-16202a70accc.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68210-4093-1 | 68210409301 | 300 TABLET, DELAYED RELEASE in 1 BOTTLE (68210-4093-1) | 2020-07-02 | 0000-00-00 | No | No | Current |